Novel pathomechanisms in inflammatory neuropathies

Abstract Inflammatory neuropathies are rare autoimmune-mediated disorders affecting the peripheral nervous system. Considerable progress has recently been made in understanding pathomechanisms of these disorders which will be essential for developing novel diagnostic and therapeutic strategies in th...

Full description

Bibliographic Details
Main Authors: David Schafflick, Bernd C. Kieseier, Heinz Wiendl, Gerd Meyer zu Horste
Format: Article
Language:English
Published: BMC 2017-11-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12974-017-1001-8
id doaj-41eadadf20964875b4fee1c0ad3429cd
record_format Article
spelling doaj-41eadadf20964875b4fee1c0ad3429cd2020-11-25T02:52:26ZengBMCJournal of Neuroinflammation1742-20942017-11-0114111710.1186/s12974-017-1001-8Novel pathomechanisms in inflammatory neuropathiesDavid Schafflick0Bernd C. Kieseier1Heinz Wiendl2Gerd Meyer zu Horste3Department of Neurology, Westfälische Wilhems-UniversityDepartment of Neurology, Medical Faculty, Heinrich-Heine-UniversityDepartment of Neurology, Westfälische Wilhems-UniversityDepartment of Neurology, Westfälische Wilhems-UniversityAbstract Inflammatory neuropathies are rare autoimmune-mediated disorders affecting the peripheral nervous system. Considerable progress has recently been made in understanding pathomechanisms of these disorders which will be essential for developing novel diagnostic and therapeutic strategies in the future. Here, we summarize our current understanding of antigenic targets and the relevance of new immunological concepts for inflammatory neuropathies. In addition, we provide an overview of available animal models of acute and chronic variants and how new diagnostic tools such as magnetic resonance imaging and novel therapeutic candidates will benefit patients with inflammatory neuropathies in the future. This review thus illustrates the gap between pre-clinical and clinical findings and aims to outline future directions of development.http://link.springer.com/article/10.1186/s12974-017-1001-8Experimental autoimmune neuritisGuillain-Barré syndromeChronic inflammatory demyelinating polyneuropathyAnimal modelTh17 cells
collection DOAJ
language English
format Article
sources DOAJ
author David Schafflick
Bernd C. Kieseier
Heinz Wiendl
Gerd Meyer zu Horste
spellingShingle David Schafflick
Bernd C. Kieseier
Heinz Wiendl
Gerd Meyer zu Horste
Novel pathomechanisms in inflammatory neuropathies
Journal of Neuroinflammation
Experimental autoimmune neuritis
Guillain-Barré syndrome
Chronic inflammatory demyelinating polyneuropathy
Animal model
Th17 cells
author_facet David Schafflick
Bernd C. Kieseier
Heinz Wiendl
Gerd Meyer zu Horste
author_sort David Schafflick
title Novel pathomechanisms in inflammatory neuropathies
title_short Novel pathomechanisms in inflammatory neuropathies
title_full Novel pathomechanisms in inflammatory neuropathies
title_fullStr Novel pathomechanisms in inflammatory neuropathies
title_full_unstemmed Novel pathomechanisms in inflammatory neuropathies
title_sort novel pathomechanisms in inflammatory neuropathies
publisher BMC
series Journal of Neuroinflammation
issn 1742-2094
publishDate 2017-11-01
description Abstract Inflammatory neuropathies are rare autoimmune-mediated disorders affecting the peripheral nervous system. Considerable progress has recently been made in understanding pathomechanisms of these disorders which will be essential for developing novel diagnostic and therapeutic strategies in the future. Here, we summarize our current understanding of antigenic targets and the relevance of new immunological concepts for inflammatory neuropathies. In addition, we provide an overview of available animal models of acute and chronic variants and how new diagnostic tools such as magnetic resonance imaging and novel therapeutic candidates will benefit patients with inflammatory neuropathies in the future. This review thus illustrates the gap between pre-clinical and clinical findings and aims to outline future directions of development.
topic Experimental autoimmune neuritis
Guillain-Barré syndrome
Chronic inflammatory demyelinating polyneuropathy
Animal model
Th17 cells
url http://link.springer.com/article/10.1186/s12974-017-1001-8
work_keys_str_mv AT davidschafflick novelpathomechanismsininflammatoryneuropathies
AT berndckieseier novelpathomechanismsininflammatoryneuropathies
AT heinzwiendl novelpathomechanismsininflammatoryneuropathies
AT gerdmeyerzuhorste novelpathomechanismsininflammatoryneuropathies
_version_ 1724730090766467072